Copyright
©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 769-782
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.769
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.769
Figure 3 Icariin enhanced the expression of angiogenesis-related markers.
A: Expression levels of angiogenesis-related genes [vascular endothelial growth factor A (VEGFA), platelet endothelial cell adhesion molecule 1 (CD31), angiopoietin-2 (Ang-2), and angiopoietin-4 (Ang-4)] in bone marrow mesenchymal stem cells (BMSCs) following treatment with icariin (ICA); B: Protein expression levels of VEGFA and CD31 by Western blot; C: Expression of VEGFA by immunofluorescence (scale bar: 100 μm); D: Expression of CD31 by immunofluorescence (scale bar: 100 μm). Data are mean ± SEM (n = 5). bP < 0.01 vs control group; cP < 0.05 and dP < 0.01 vs 1 μM ICA group. ICA: Icariin; VEGFA: Vascular endothelial growth factor A; CD31: Platelet endothelial cell adhesion molecule 1; Ang-2: Angiopoietin-2; Ang-4: Angiopoietin-4; qRT-PCR: Quantitative real-time polymerase chain reaction.
- Citation: Zheng S, Hu GY, Li JH, Zheng J, Li YK. Icariin accelerates bone regeneration by inducing osteogenesis-angiogenesis coupling in rats with type 1 diabetes mellitus. World J Diabetes 2024; 15(4): 769-782
- URL: https://www.wjgnet.com/1948-9358/full/v15/i4/769.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i4.769